Alvotech Company Leadership
| ALVO Stock | USD 5.37 0.05 0.92% |
Alvotech employs about 1 K people. The company is managed by 28 executives with a total tenure of roughly 2362 years, averaging almost 84.0 years of service per executive, having 36.14 employees per reported executive. Analysis of Alvotech's management performance can provide insight into the firm performance.
Alvotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0198 % which means that it generated a profit of $0.0198 on every $100 spent on assets. This is way below average. Alvotech's management efficiency ratios could be used to measure how well Alvotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2026, Return On Capital Employed is likely to grow to 0.06, while Return On Tangible Assets are likely to drop (0.24). At this time, Alvotech's Total Current Assets are very stable compared to the past year. As of the 1st of February 2026, Intangibles To Total Assets is likely to grow to 0.04, while Total Assets are likely to drop about 895.9 M.As of the 1st of February 2026, Common Stock Shares Outstanding is likely to drop to about 183.2 M. In addition to that, Net Loss is likely to grow to about (439.1 M)Alvotech holds a total of 311.6 Million outstanding shares. Alvotech shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.76 percent of Alvotech outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Alvotech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Alvotech, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Alvotech Workforce Comparison
Alvotech is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 48,961. Alvotech holds roughly 1,012 in number of employees claiming about 2.07% of equities under Health Care industry.
Alvotech Profit Margins
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.48 | 0.51 |
|
|
Alvotech Benchmark Summation
Operator |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Alvotech Price Series Subtraction is a subtraction of Alvotech price series from its benchmark/peer..
Alvotech Notable Stakeholders
An Alvotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Alvotech often face trade-offs trying to please all of them. Alvotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Alvotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vilhelm Wessman | Founder CEO | Profile | |
| Christina Siniscalchi | Interim Officer | Profile | |
| Ming Li | Chief Officer | Profile | |
| Harshika Sarbajna | Senior America | Profile | |
| RoseMarie Ohlsson | Chief Officer | Profile | |
| Giedrius Zunda | Chief Officer | Profile | |
| Sean Gaskell | Chief Officer | Profile | |
| Uri Hillel | Chief Officer | Profile | |
| Johann Johannsson | Executive MA | Profile | |
| Faysal Kalmoua | Chief Officer | Profile | |
| Sigridur Gudlaugsdottir | VP HR | Profile | |
| Jenny Steingrimsdottir | Vice Culture | Profile | |
| Robert Wessman | Founder Directors | Profile | |
| Benedikt Stefansson | Vice Communications | Profile | |
| Sarah Macleod | Head Communications | Profile | |
| Trisha Durant | exNorth Operation | Profile | |
| Sandra Casaca | Chief Officer | Profile | |
| Anil Okay | Chief Officer | Profile | |
| Balaji MD | Chief Officer | Profile | |
| Kathryn Gunnarsson | Senior Experience | Profile | |
| Linda Jonsdottir | Chief Officer | Profile | |
| Joel Morales | Chief Officer | Profile | |
| Joseph McClellan | Chief Officer | Profile | |
| Eva Gunnlaugsdottir | Vice Culture | Profile | |
| Tanya Zharov | General Counsel | Profile | |
| Mark Levick | Chief Officer | Profile | |
| Agne Pasko | Vice Development | Profile | |
| Anthony III | Chief Officer | Profile |
About Alvotech Management Performance
The success or failure of an entity such as Alvotech often depends on how effective the management is. Alvotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Alvotech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Alvotech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.22) | (0.24) | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | (0.22) | (0.23) | |
| Return On Equity | 0.51 | 0.48 |
Alvotech Workforce Analysis
Traditionally, organizations such as Alvotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Alvotech within its industry.Alvotech Manpower Efficiency
Return on Alvotech Manpower
| Revenue Per Employee | 483.9K | |
| Revenue Per Executive | 17.5M | |
| Net Loss Per Employee | 229.1K | |
| Net Loss Per Executive | 8.3M | |
| Working Capital Per Employee | 258.5K | |
| Working Capital Per Executive | 9.3M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Will Biotechnology sector continue expanding? Could Alvotech diversify its offerings? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alvotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.58) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Understanding Alvotech requires distinguishing between market price and book value, where the latter reflects Alvotech's accounting equity. The concept of intrinsic value—what Alvotech's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alvotech's price substantially above or below its fundamental value.
Understanding that Alvotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alvotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alvotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.